Vivani Medical, Inc. (VANI)
NASDAQ: VANI · Real-Time Price · USD
1.400
-0.010 (-0.71%)
At close: Dec 5, 2025, 4:00 PM EST
1.370
-0.030 (-2.15%)
After-hours: Dec 5, 2025, 6:15 PM EST
Vivani Medical Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
37
Market Cap
102.13M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| UnitedHealth Group | 435.16B |
| Johnson & Johnson | 92.15B |
| Merck & Co. | 64.24B |
| AbbVie | 59.64B |
| Eli Lilly and Company | 59.42B |
| AstraZeneca | 58.13B |
| Novartis AG | 56.37B |
| Novo Nordisk | 49.58B |
VANI News
- 22 days ago - Vivani Medical Provides Business Update and Reports Third Quarter 2025 Financial Results - GlobeNewsWire
- 5 weeks ago - Vivani Medical, Inc. Announces Closing of Common Stock Offering - GlobeNewsWire
- 5 weeks ago - Vivani Medical, Inc. Announces Pricing of Common Stock Offering - GlobeNewsWire
- 2 months ago - Vivani Medical Withdraws Record Date for Cortigent Neuromodulation Subsidiary Spin-Off - GlobeNewsWire
- 2 months ago - Vivani Medical to Present at the Emerging Growth Conference on September 25, 2025 - GlobeNewsWire
- 2 months ago - Vivani Medical Announces Record Date for Spin-off of Cortigent Neuromodulation Subsidiary to Shareholders - GlobeNewsWire
- 3 months ago - Vivani Medical Provides Update on Clinical Development Plans for NPM-139 Semaglutide Implant for Chronic Weight Management - GlobeNewsWire
- 3 months ago - Vivani Medical CEO Adam Mendelsohn to Present at the H.C. Wainwright 27th Annual Global Investment Conference on September 10, 2025 - GlobeNewsWire